{"id":"humulinr","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Humulin®R","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T07:00:53.385997+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T07:01:01.123353+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Humulin®R","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T07:01:01.994834+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL89731/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T07:01:02.900249+00:00"}},"_dailymed":{"setId":"b519bd83-038c-4ec5-a231-a51ec5cc291f","title":"HUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION HUMULIN R (INSULIN HUMAN) INJECTION, SOLUTION [ELI LILLY AND COMPANY]"},"_scrapedAt":"2026-03-28T04:40:29.022Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T07:01:04.816403+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT07364669","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Pisa S.A. de C.V.","startDate":"2024-10-24","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT05742243","phase":"PHASE2","title":"Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2023-02-13","conditions":"Type 1 Diabetes, Diabetes Mellitus, Type 1","enrollment":68},{"nctId":"NCT03857321","phase":"PHASE2","title":"Study of Nasal Insulin to Fight Forgetfulness - Device Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-04-12","conditions":"Mild Cognitive Impairment, Cognitive Impairment","enrollment":20},{"nctId":"NCT05081219","phase":"PHASE2","title":"SNIFF - Combo INI+EMPA Trial","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-09-14","conditions":"Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease","enrollment":47},{"nctId":"NCT07201155","phase":"","title":"The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-05-01","conditions":"Hyperglycemia in Critically Ill Patients","enrollment":55},{"nctId":"NCT03903016","phase":"PHASE1","title":"A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-03-26","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT06794658","phase":"NA","title":"EFFICACY OF REMOTE MONITORING OF PATIENTS WITH DIABETES UNDER INSULIN TREATMENT, BY USING Caaring SOFTWARE","status":"RECRUITING","sponsor":"Persei Vivarium","startDate":"2024-12-11","conditions":"Diabetes Mellitus","enrollment":200},{"nctId":"NCT05006599","phase":"PHASE2","title":"SNIFF - 3-Week Aptar CPS Device","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2025-05","conditions":"Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease, Early Onset","enrollment":""},{"nctId":"NCT04199767","phase":"PHASE2","title":"SNIFF Multi-Device Study 2","status":"SUSPENDED","sponsor":"Wake Forest University Health Sciences","startDate":"2020-07-16","conditions":"Mild Cognitive Impairment, Cognitive Impairment","enrollment":30},{"nctId":"NCT01528189","phase":"NA","title":"Effect of High Dose Insulin on Infectious Complications Following Major Surgery","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2018-10-05","conditions":"Surgical Site Infection After Major Surgery","enrollment":460},{"nctId":"NCT04227769","phase":"PHASE2","title":"IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes","status":"TERMINATED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-01-13","conditions":"Diabetes Mellitus Type 2 in Obese, Inflammation, Metabolic Disease","enrollment":18},{"nctId":"NCT01767909","phase":"PHASE2, PHASE3","title":"The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2014-01-08","conditions":"Amnestic Mild Cognitive Impairment, Alzheimer's Disease","enrollment":240},{"nctId":"NCT05754424","phase":"PHASE1","title":"AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study","status":"COMPLETED","sponsor":"Arecor Limited","startDate":"2023-02-27","conditions":"Diabetes Mellitus, Type 2","enrollment":41},{"nctId":"NCT05679596","phase":"NA","title":"Exogenous Ketosis During Bed Rest in Older Adults","status":"COMPLETED","sponsor":"McGill University","startDate":"2023-02-27","conditions":"Muscle Protein Synthesis, Muscle Atrophy, Insulin Sensitivity","enrollment":30},{"nctId":"NCT03915613","phase":"PHASE1, PHASE2","title":"Brain Insulin Resistance in Mood Disorders","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2021-10-06","conditions":"Major Depressive Disorder, Bipolar Disorder, Anhedonia","enrollment":150},{"nctId":"NCT06050343","phase":"NA","title":"Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method","status":"COMPLETED","sponsor":"Geropharm","startDate":"2018-02-19","conditions":"Bioequivalence, Therapeutic Equivalency","enrollment":20},{"nctId":"NCT01308437","phase":"PHASE3","title":"Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics","status":"TERMINATED","sponsor":"Wockhardt","startDate":"2011-03","conditions":"Type I Diabetes","enrollment":134},{"nctId":"NCT05413863","phase":"PHASE1","title":"Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects","status":"COMPLETED","sponsor":"Biocon Limited","startDate":"2022-05-30","conditions":"Healthy Volunteers","enrollment":78},{"nctId":"NCT02102243","phase":"PHASE4","title":"Neural Mechanism of Aldosterone-induced Insulin Resistance","status":"WITHDRAWN","sponsor":"Wanpen Vongpatanasin","startDate":"2010-11","conditions":"Hypertension","enrollment":""},{"nctId":"NCT04949867","phase":"PHASE4","title":"Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2021-05-20","conditions":"Type 1 Diabetes","enrollment":11},{"nctId":"NCT01613807","phase":"PHASE4","title":"Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes","status":"COMPLETED","sponsor":"Sansum Diabetes Research Institute","startDate":"2008-10","conditions":"Gestational Diabetes Mellitus","enrollment":40},{"nctId":"NCT04022317","phase":"PHASE1","title":"Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R","status":"COMPLETED","sponsor":"Biocon Limited","startDate":"2019-06-18","conditions":"Healthy Volunteer","enrollment":42},{"nctId":"NCT03495908","phase":"NA","title":"Regular Insulin vs Rapid Insulin Delivered by V-Go","status":"COMPLETED","sponsor":"East Coast Institute for Research","startDate":"2018-04-09","conditions":"Type 2 Diabetes, Type 2 Diabetes Mellitus","enrollment":136},{"nctId":"NCT00705536","phase":"PHASE1","title":"Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20","status":"COMPLETED","sponsor":"Halozyme Therapeutics","startDate":"2007-12","conditions":"Diabetes Mellitus","enrollment":26},{"nctId":"NCT02758691","phase":"PHASE1","title":"fMRI Study of Effects of Nasal Insulin on Memory","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2015-12","conditions":"Human Memory, Intranasal Insulin","enrollment":45},{"nctId":"NCT00803972","phase":"PHASE1","title":"Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20","status":"COMPLETED","sponsor":"Halozyme Therapeutics","startDate":"2008-11","conditions":"Healthy Volunteers","enrollment":42},{"nctId":"NCT02982551","phase":"EARLY_PHASE1","title":"Insulin Modulation of fMRI Connectivity in Healthy Adults","status":"WITHDRAWN","sponsor":"University of Pittsburgh","startDate":"2016-01-01","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT00567775","phase":"PHASE2","title":"Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-10-21","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":27},{"nctId":"NCT00593255","phase":"PHASE4","title":"Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2004-07","conditions":"Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":220},{"nctId":"NCT00071448","phase":"PHASE3","title":"Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-06","conditions":"Diabetes, Diabetes Mellitus, Type 1","enrollment":378},{"nctId":"NCT02727231","phase":"NA","title":"Closing the Loop in Adults With Type 1 Diabetes and HbA1C<7.5% Under Free Living Conditions","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2016-03","conditions":"Type 1 Diabetes","enrollment":29},{"nctId":"NCT02635243","phase":"PHASE1","title":"A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia","status":"WITHDRAWN","sponsor":"Sanofi","startDate":"2016-04","conditions":"Type 1 Diabetes Mellitus","enrollment":""},{"nctId":"NCT02324309","phase":"PHASE1, PHASE2","title":"BIOD-531 vs. Humalog Mix 75/25 vs. Humulin R U-500 Post-Meal Glucose Control in Patients With Severe Insulin Resistance","status":"COMPLETED","sponsor":"Biodel","startDate":"2014-05","conditions":"Diabetes Mellitus","enrollment":12},{"nctId":"NCT02634515","phase":"PHASE1","title":"Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics of Julphar Insulin R and Huminsulin® Normal","status":"COMPLETED","sponsor":"Julphar Gulf Pharmaceutical Industries","startDate":"2014-12","conditions":"Diabetes Mellitus","enrollment":26},{"nctId":"NCT01961622","phase":"NA","title":"Closing the Loop in Adults With Sub-optimally Controlled Type 1 Diabetes Under Free Living Conditions","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2014-04","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT01666028","phase":"PHASE2","title":"Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2012-11","conditions":"Type 1 Diabetes","enrollment":18},{"nctId":"NCT00439972","phase":"PHASE2","title":"Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity","status":"UNKNOWN","sponsor":"University of Washington","startDate":"2007-02","conditions":"Contraception","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL89731"},"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Humulin®R","genericName":"Humulin®R","companyName":"Biocon Limited","companyId":"biocon-limited","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T07:01:04.816403+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}